--- title: "MetLife Q2 2026 Earnings: Adjusted Profit Growth Outpaces GAAP Net Income" type: "News" locale: "en" url: "https://longbridge.com/en/news/295024054.md" description: "MetLife reported Q2 2026 total revenue of $19.15 billion, up 10% year-over-year. Adjusted earnings rose 15% to $1.57 billion with adjusted EPS increasing 20% to $2.43, driven by favorable underwriting and volume growth in Group Benefits and Asia. In contrast, GAAP net income grew only 1% to $705 million due to investment-related losses from derivatives and market fluctuations. Adjusted ROE improved to 17.0%, while insider transactions showed net purchases over the past six months." datetime: "2026-08-05T22:21:54.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295024054.md) - [en](https://longbridge.com/en/news/295024054.md) - [zh-HK](https://longbridge.com/zh-HK/news/295024054.md) --- # MetLife Q2 2026 Earnings: Adjusted Profit Growth Outpaces GAAP Net Income MetLife (NYSE: MET) reported Q2 2026 total revenue of $19.15 billion, up from $17.34 billion a year earlier, while GAAP diluted EPS rose 6% to $1.09 from $1.03. Adjusted earnings increased 15% to $1.57 billion and adjusted EPS rose 20% to $2.43, driven by favorable underwriting and broad-based volume growth. Group Benefits and Asia led segment earnings growth, while investment-related items limited GAAP net income growth to 1%. ## Core financial results Premiums, fees and other revenues increased 7% to $13.65 billion. On an adjusted basis and excluding pension risk transfers, the measure rose 5% to $13.01 billion, with growth across every operating segment. Net investment income also contributed to revenue growth, although the GAAP and adjusted measures reflected different drivers. GAAP net investment income increased 18%, while adjusted net investment income rose 7% on asset growth and investment in a higher-rate environment. Metric Q2 2026 Q2 2025 Year-over-year change Total revenue $19,154 million $17,340 million Approximately 10% Premiums, fees and other revenues $13,652 million $12,748 million 7% Net investment income $6,702 million $5,661 million 18% Net income $705 million $698 million 1% GAAP diluted EPS $1.09 $1.03 6% Adjusted earnings $1,573 million $1,362 million 15% Adjusted EPS $2.43 $2.02 20% Adjusted ROE 17.0% 14.6% Up 2.4 percentage points ## Business and segment performance All operating segments reported higher adjusted earnings. Group Benefits and Asia produced the largest increases, while Retirement and Income Solutions recorded substantial volume growth but only a modest earnings gain because lower variable investment income offset part of the benefit. Segment Q2 2026 adjusted earnings Year-over-year change Main disclosed drivers Group Benefits $503 million 25% Favorable underwriting and volume growth Retirement and Income Solutions $377 million 2% Recurring interest margins and volume, partly offset by lower variable investment income Asia $420 million 21%; 25% constant currency Equity markets, higher variable investment income and volume Latin America $268 million 15%; 4% constant currency Volume, encaje returns and taxes, partly offset by Mexico’s VAT change EMEA $108 million 8%; 11% constant currency Volume growth, partly offset by higher expenses MetLife Investment Management $57 million 6% Business growth and expense management Group Benefits’ adjusted premiums, fees and other revenues excluding participating contracts grew 4%, supported by National Accounts and Regional Business. Retirement and Income Solutions increased the comparable measure excluding pension risk transfers by 19%, mainly due to U.K. longevity reinsurance and structured settlement sales. Asia’s adjusted premiums, fees and other revenues were flat as reported but increased 6% at constant currency. Latin America posted 16% reported growth and 6% constant-currency growth, indicating that currency translation contributed materially to its reported results. MetLife Investment Management’s other revenue rose 34% to $317 million, primarily reflecting the PineBridge Investments acquisition and business growth. Assets under management increased 20% to $748.1 billion. Corporate & Other’s adjusted loss widened to $160 million from $142 million. Adjusted earnings rose 15%, but GAAP net income increased only 1%. The difference reflected investment-related items that are excluded from MetLife’s adjusted results: after-tax net investment losses were $338 million, while after-tax derivative losses were $610 million. The derivative losses were driven by stronger equity markets, higher long-term interest rates and a stronger U.S. dollar. At the same time, GAAP net investment income increased 18%, primarily because of estimated fair-value increases in certain securities that do not qualify as separate accounts under GAAP. Adjusted net investment income grew a more moderate 7%, reflecting asset growth and the higher-rate investment environment. Investors therefore need to distinguish recurring investment income from market-sensitive accounting effects when comparing GAAP and adjusted profitability. ## Profitability and balance-sheet capacity Adjusted ROE improved to 17.0% from 14.6%, reaching the top of MetLife’s stated range for a second consecutive quarter. GAAP ROE, however, edged down to 11.5% from 11.7%, consistent with the limited growth in reported net income. Expense measures moved higher. The reported expense ratio increased to 21.7% from 19.8%, while the adjusted expense ratio excluding notable items and pension risk transfers rose to 20.8% from 19.8%. The comparable direct expense ratio increased to 12.1% from 11.7%, though the company said it remained on track for its annual target. Holding-company cash and liquid assets totaled $3.4 billion at quarter-end, within MetLife’s target range. The company returned more than $1.1 billion through share repurchases and common dividends. Book value per share increased 8% to $38.59, while adjusted book value per share rose 3% to $57.71. ## Recent insider transactions The supplied insider dataset reports 388,228 shares classified as purchases across 51 transactions during the preceding six months, compared with 21,312 shares sold in one transaction. That produced reported net purchases of 366,916 shares, equal to 0.30% of total insider holdings of 105.62 million shares. The latest ten reported entries were direct stock awards to directors on June 16, 2026, rather than open-market purchases. Transaction values are those shown in the supplied data. Insider Role Transaction Reported value Date Daniel S. Glaser Director Stock award at $87.40 per share $51,304 June 16, 2026 Robert Glenn Hubbard Director Stock award at $87.40 per share $88,798 June 16, 2026 Michelle Seitz Director Stock award at $0.00 per share $0 June 16, 2026 Laura J. Hay Director Stock award at $87.40 per share $51,304 June 16, 2026 Mark A. Weinberger Director Stock award at $0.00 per share $0 June 16, 2026 Christian Stephane Mumenthaler Director Stock award at $87.40 per share $51,304 June 16, 2026 Diana L. McKenzie Director Stock award at $87.40 per share $51,304 June 16, 2026 Jeh Charles Johnson Director Stock award at $87.40 per share $51,304 June 16, 2026 Carla A. Harris Director Stock award at $87.40 per share $51,304 June 16, 2026 William E. Kennard Director Stock award at $87.40 per share $51,304 June 16, 2026 Because these entries were compensation-related awards, they should not be treated as equivalent to discretionary open-market buying. ## Risks investors should watch - **Market and hedging volatility:** Investment and derivative losses materially limited GAAP net income growth. Changes in equity markets, interest rates and the U.S. dollar can continue to widen the gap between reported and adjusted results. - **Rising expense ratios:** The reported, adjusted and direct expense ratios all increased. Continued expense growth could reduce the benefit from underwriting and business-volume gains. - **Variable investment income exposure:** Higher variable investment income supported Asia, while lower variable investment income restrained Retirement and Income Solutions. Changes in this income source can produce uneven segment earnings. - **Currency and tax effects:** Asia’s reported revenue trend lagged its constant-currency performance, while currency enhanced Latin America’s reported growth. The Mexico VAT change also partially offset Latin American earnings gains. ## Summary MetLife’s Q2 2026 results showed broad operating momentum, led by favorable Group Benefits underwriting, stronger Asia earnings and volume growth across the company. Adjusted profitability and ROE improved, but market-related losses kept GAAP net income nearly flat and expense ratios moved higher. The main items to monitor are whether operating growth can continue to outweigh expense pressure and how investment, derivative and currency movements affect reported results. Find out more ### Related Stocks - [MET.US](https://longbridge.com/en/quote/MET.US.md) - [MET-A.US](https://longbridge.com/en/quote/MET-A.US.md) - [MET-F.US](https://longbridge.com/en/quote/MET-F.US.md) - [MET-E.US](https://longbridge.com/en/quote/MET-E.US.md) ## Related News & Research - [MetLife declares Series A preferred dividend of $0.31 a share](https://longbridge.com/en/news/296141813.md) - [MetLife Declares Third Quarter 2026 Preferred Stock Dividends | MET Stock News](https://longbridge.com/en/news/296142723.md) - [HBK Sorce Advisory LLC Makes New Investment in MetLife, Inc. $MET](https://longbridge.com/en/news/296088728.md) - [Pacer Advisors Inc. Lowers Stock Holdings in MetLife, Inc. $MET](https://longbridge.com/en/news/295296842.md) - [Do Wall Street Analysts Like MetLife Stock?](https://longbridge.com/en/news/285935558.md)